ReviewDer Internist2019
[Incretin-based co- and tri-agonists : Innovative polypharmacology for the treatment of obesity and diabetes].
A Harger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ReviewDer Internist2019
A Harger et al.PubMed ↗Publisher ↗
No numbers read from the abstract.